LDS/Medical Tests/TNNT2 (Troponin T) Gene Mutation Analysis

TNNT2 (Troponin T) Gene Mutation Analysis

The TNNT2 gene, located in the long (q) arm of chromosome 1 at position 32.1 encodes for troponin T (cTnT). Troponin T, along with troponin I, and C, form the troponin complex. The troponin complex together with actin and tropomyosin form the contractile elements of cardiac and skeletal muscle. Cardiac troponin T is 36-kDa protein consisting of 297 amino acids and is the tropomyosin-binding portion of the troponin complex. It possesses two major domains, the N- terminal domain that interacts with tropomyosin, and the C-terminal domain that binds to tropomyosin, troponin C, and troponin I. Binding of troponin T to tropomyosin is responsible for the positioning of the troponin complex on the thin filaments. Mutations in this gene are associated with hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), familial restrictive cardiomyopathy and left ventricular noncompaction.

Familial HCM is typically inherited as an autosomal dominant genetic heart disorder characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. Pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels. The majority of HCM patients are asymptomatic although about 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intra-familial variability ranging from benign to malignant forms with a high risk of cardiac failure and sudden cardiac death. HCM is the most common cause of sudden cardiac death in young people with the prevalence of 1:500 in the general adult population. The majority of the mutations in HCM are missense, insertion/deletion and frame-shift mutations. Mutations in the TNNT2 gene account for about 4% of HCM cases.

Dilated cardiomyopathy (DCM) is most commonly inherited in an autosomal dominant or X-linked manner. DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. DCM is the most common cause of congestive heart failure in young patients, although, cardiac arrythmias, syncope and sudden death may also occur. It has a prevalence of approximately 1 per 2,500 in the adult population. Many people with dilated cardiomyopathy have no or only minor symptoms and live a normal life. Other individuals with DCM may develop symptoms such as fatigue, weight loss, fainting, palpitations, chest pain and sudden death. Mutations in TNNT2 account for about 3% of inherited DCM cases.

Restrictive cardiomyopathy (RCM) is a rare cardiac disorder that manifests primarily as an abnormality of diastolic filling, which is due to reduced ventricular compliance or increased stiffness This results in reduced diastolic volume with preserved systolic function. The altered protein due to mutation typically cannot bind to actin. As a result, heart muscle relaxation is disrupted, leading to abnormal heart function and impaired blood flow. Symptoms such as fatigue and fainting may be seen during the disease.

Left ventricular noncompaction (LVNC) is characterized by a pattern of prominent trabecular meshwork and deep intertrabecular recesses communicating within the left ventricular (LV) cavity. LVNC, like other forms of inherited cardiomyopathy, is genetically heterogeneous and can be inherited as an autosomal dominant or X-linked recessive disorder.

  • As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy, familial restrictive cardiomyopathy
  • Carrier screening for relatives and those with the family history
  • Prenatal carrier screening for those with the family history
Mutation or pathogenic variants in TNNT2 gene. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants.

Negative for mutations analyzed (No pathogenic variant or mutation detected)

Target sequencing by next generation sequencing (NGS), deletion/duplication analysis by quantitative multiplex PCR, long-range PCR, multiplex ligation dependent probe amplification (MLPA).

Whole blood (EDTA).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: Unacceptable
Creatine kinase (CK), CK-MB, lactate dehydrogenase (LDH), troponin T, myosin light chain-1 (MLC-1), electrocardiogram, chest X-ray, exercise stress echocardiography, cardiac catheterization and magnetic resonance imaging (MRI).
1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Biomed Res Int. 2014;2014: 907360. [PMID: 25110706]
  • Circ J. 2019;83: 1908-1916. [PMID: 31308319]
  • Med Sci Monit. 2015 Nov 3;21:3343-7. [PMID: 26525169]
  • Gene. 2016; 582: 1–13. [PMID: 26774798]
  • Heart Fail Rev. 2019;24: 439-459. [PMID: 30852773]
  • Eur J Med Genet. 2018;61: 8-10. [PMID: 29024827]
  • Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/TNNT2#
  • Post-Genomic Cardiology In: chapter 13, Cardiomyopathies, 363-413. doi:10.1016/b978-012373698-7/50013-9